Danielle Boyle: Honoured to Chair ITP Symposium at the EHA 2026
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, shared on LinkedIn:
”I’m incredibly honoured to be chairing an upcoming symposium at the EHA 2026 Congress next month.
To not only be invited to contribute but also to chair a panel of such highly esteemed clinicians, alongside a fellow patient advocate, is something I’m genuinely proud of.
These are individuals who are shaping the future of ITP care, and it is a privilege to help guide an important and meaningful discussion while continuing to keep patients at the centre of everything we strive to achieve.
What makes this opportunity even more significant is what it represents.
Seeing patient organisations included at this level is a strong step in the right direction and a clear reflection of the shift towards putting patients at the centre of care, research, and decision-making.
This is exactly where we need to be.
Collaborative, inclusive, and grounded in lived experience alongside clinical expertise.
If you are attending EHA 2026 this year, I would love for you to join us.
You can find the session details.
I am looking forward to being part of the conversation and continuing to advocate for a more patient-centred future in ITP.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 17:49Alan Nurden: Safer Antithrombotic Therapy Through GPVI
-
Jul 7, 2026, 17:29Anticoagulation Reversal in 2026: Are We Winning the Bleeding Battle? – Francisco Chacón-Lozsán
-
Jul 7, 2026, 17:25Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
-
Jul 7, 2026, 17:14Shabneez Hussain: Blood Transfusion Professionals Connecting at ISBT 2026
-
Jul 7, 2026, 17:04Mariam Swidan: Vitamin B12 Deficiency and the Hidden Risk of Neurological Damage
-
Jul 7, 2026, 16:53Heghine Khachatryan: Breaking Barriers in Bleeding Disorder Care for Women and Girls
-
Jul 7, 2026, 16:39Why Medical Alert Identification Matters in Bleeding Disorders – South African Haemophilia
-
Jul 7, 2026, 16:21Hannah Omunakwe: When Blood Becomes the Limiting Treatment in Sickle Cell Disease
-
Jul 7, 2026, 15:54Barbara Lovrencic: Giving the ITP Patient Voice a Stronger Evidence Base